These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 3026617

  • 21. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells.
    Takuwa N, Takuwa Y, Ohue Y, Mukai H, Endoh K, Yamashita K, Kumada M, Munekata E.
    Cancer Res; 1990 Jan 15; 50(2):240-4. PubMed ID: 1688510
    [Abstract] [Full Text] [Related]

  • 22. [The role of gastrin releasing peptide as a lung growth factor].
    Thomas F, Morin A, Moreau JP, Calvo F, Poupon MF.
    Rev Mal Respir; 1992 Jan 15; 9(2):125-37. PubMed ID: 1565825
    [Abstract] [Full Text] [Related]

  • 23. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
    Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K.
    Cancer Res; 1994 Nov 15; 54(22):5895-901. PubMed ID: 7954420
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.
    Ciomei M, Pastori W, Pastori A, de Castiglione R, Gozzini L, Corradi F.
    Anticancer Res; 1993 Nov 15; 13(1):75-9. PubMed ID: 8386497
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
    Koppán M, Halmos G, Arencibia JM, Lamharzi N, Schally AV.
    Cancer; 1998 Oct 01; 83(7):1335-43. PubMed ID: 9762934
    [Abstract] [Full Text] [Related]

  • 29. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues.
    Mahmoud S, Palaszynski E, Fiskum G, Coy DH, Moody TW.
    Life Sci; 1989 Oct 01; 44(5):367-73. PubMed ID: 2536883
    [Abstract] [Full Text] [Related]

  • 30. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
    Williams BY, Schonbrunn A.
    Cancer Res; 1994 Feb 01; 54(3):818-24. PubMed ID: 8306345
    [Abstract] [Full Text] [Related]

  • 31. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
    Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE.
    Cancer Res; 1995 May 15; 55(10):2212-9. PubMed ID: 7538048
    [Abstract] [Full Text] [Related]

  • 32. Breast cancer cell-associated endopeptidase EC 24.11 modulates proliferative response to bombesin.
    Burns DM, Walker B, Gray J, Nelson J.
    Br J Cancer; 1999 Jan 15; 79(2):214-20. PubMed ID: 9888460
    [Abstract] [Full Text] [Related]

  • 33. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
    Halmos G, Schally AV.
    Proc Natl Acad Sci U S A; 1997 Feb 04; 94(3):956-60. PubMed ID: 9023364
    [Abstract] [Full Text] [Related]

  • 34. Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines.
    Munker M, Munker R, Saxton RE, Koeffler HP.
    Cancer Res; 1987 Aug 01; 47(15):4081-5. PubMed ID: 3038306
    [Abstract] [Full Text] [Related]

  • 35. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway.
    Seckl MJ, Seufferlein T, Rozengurt E.
    Cancer Res; 1994 Dec 01; 54(23):6143-7. PubMed ID: 7525056
    [Abstract] [Full Text] [Related]

  • 36. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J, Reile H, Halmos G, Groot K, Schally AV.
    Cancer Res; 1994 Jan 01; 54(1):169-74. PubMed ID: 7903203
    [Abstract] [Full Text] [Related]

  • 37. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
    Aguayo SM, Miller Y, Boose D, Holley M, Portanova LB, Schuyler KD, Kane MA.
    Cell Growth Differ; 1996 May 01; 7(5):563-72. PubMed ID: 8732666
    [Abstract] [Full Text] [Related]

  • 38. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R.
    Cancer Res; 2003 Oct 01; 63(19):6272-81. PubMed ID: 14559814
    [Abstract] [Full Text] [Related]

  • 39. Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer.
    Scagliotti GV, Piani M, Gatti E, Gozzelino F, Albera C, Pozzi E.
    Eur Respir J; 1989 Sep 01; 2(8):746-50. PubMed ID: 2553476
    [Abstract] [Full Text] [Related]

  • 40. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
    Stangelberger A, Schally AV, Varga JL, Zarandi M, Szepeshazi K, Armatis P, Halmos G.
    Clin Cancer Res; 2005 Jan 01; 11(1):49-57. PubMed ID: 15671527
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.